The activation of mutant K-Ras under its own promoter, using Cre recombinase under an acinar specific (elastase) promoter can reproduce pancreatic tumorigenesis, but only if K-Ras is expressed during development or following cerulean-induced pancreatitis [15]. The gene discussed is KRAS; the disease is pancreatitis.